Intent To Grant an Exclusive License for U.S. Government-Owned Invention, 1713 [2019-01055]

Download as PDF Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices Administration (FDA) on December 19, 2006. Review of the patent term extension application indicates that, except for permission to market or use the product commercially, the subject patent would be eligible for an extension of the patent term under 35 U.S.C. 156, and that the patent should be extended for one year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory review period will continue beyond the original expiration date of the patent, March 31, 2019, interim extension of the patent term under 35 U.S.C. 156(d)(5) is appropriate. An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. Patent No. 7,534,790 is granted for a period of one year from the original expiration date of the patent. Dated: January 29, 2019. Robert Bahr, Deputy Commissioner for Patent Examination Policy, United States Patent and Trademark Office. [FR Doc. 2019–01049 Filed 2–4–19; 8:45 am] DEPARTMENT OF DEFENSE Department of the Army Intent To Grant an Exclusive License for U.S. Government-Owned Invention Department of the Army, DoD. Notice. AGENCY: In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, Attn: Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: Dr. Paul Michaels, Office of Research & Technology Applications, (301) 619– 4145. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619– 7808, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to United States Patent 7,867,983, filed March 25, 2008, entitled ‘‘Methods to Protect Skeletal Muscle Against Injury,’’ to the University of Connecticut, having its principal place of business at 400 Farmington Avenue, Farmington, CT 06032. SUMMARY: VerDate Sep<11>2014 17:22 Feb 04, 2019 Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2019–01055 Filed 2–4–19; 8:45 am] BILLING CODE 5001–03–P DEPARTMENT OF DEFENSE Office of the Secretary Vietnam War Commemoration Advisory Committee; Notice of Federal Advisory Committee Meeting; Amendment Chief Management Officer, Vietnam War Commemoration Advisory Committee, Department of Defense. ACTION: Notice of federal advisory committee meeting. AGENCY: On Wednesday, December 26, 2018, the Department of Defense (DoD) published a notice to announce that the following Federal Advisory Committee meeting of the Vietnam War Commemoration Advisory Committee will be held on February 8, 2019. Subsequent to the publication of this notice, the start time for this meeting has changed. The public is asked to arrive no later than 10:15 a.m. The meeting will begin promptly at 10:30 a.m. All other information in the December 26, 2018 notice remains the same. DATES: Open to the public Friday, February 8, 2019 from 10:15 a.m. to 4:00 p.m. ADDRESSES: The address of the open meeting is 241 18th Street South, Room 101, Arlington VA 22202. FOR FURTHER INFORMATION CONTACT: Mrs. Marcia L. Moore, 703–571–2005 (Voice), 703–692–4691 (Facsimile), marcia.l.moore12.civ@mail.mil (Email) or Mr. Mark Franklin, 703–697–4849 (Voice), mark.r.franklin.civ@mail.mil (Email). Mailing address is DOD Vietnam War Commemoration Program Office, 241 18th Street South, Suite 101, Arlington, VA 22202. Website: https:// www.vietnamwar50th.com. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of the Department of Defense (DoD) and the Designated Federal Officer, the Vietnam War Commemoration Advisory Committee was unable to provide public SUMMARY: BILLING CODE 3510–16–P ACTION: Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). Jkt 247001 PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 1713 notification required by 41 CFR 102– 3.150(a) concerning its need to amend the previously published notice about the February 8, 2019 meeting of the Vietnam War Commemoration Advisory Committee. Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 CFR 102–3.150(b), waives the 15calendar day notification requirement. This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. Purpose of the Meeting: The Department of Defense is publishing this notice to announce the following Federal advisory committee meeting of the Vietnam War Commemoration Advisory Committee. This meeting is open to the public. The Committee is asked to provide advice on the concept and design of the types of commemoration events the Vietnam War Commemoration Office (VWC) should consider supporting or coordinating during the close-out phase from 2023 through 2025. The objective for this meeting is to finalize the Advisory Committee’s recommendations. Agenda: The Committee will convene from 10:15 a.m. to 4:00 p.m. on February 8, 2019 to finalize the Committee’s recommendations on the concept and types of commemoration events the Vietnam War Commemoration Office (VWC) should consider supporting or coordinating during the close-out phase from 2023 through 2025. Meeting Accessibility: Special Accommodations: Individuals requiring special accommodations to access the public meeting should contact Mrs. Marcia Moore or Mr. Franklin at the number listed in the FOR FURTHER INFORMATION CONTACT section by February 1, 2019 so that appropriate arrangements can be made. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140, and section 10(a)(3) of the Federal Advisory Committee Act of 1972, the public or interested organizations may submit written comments to the Committee about its mission and topics pertaining to this public meeting. Written comments should be received by the DFO by February 1, 2019. Written comments should be submitted via email to the address for the DFO given in the FOR FURTHER INFORMATION CONTACT section in either Adobe Acrobat or Microsoft Word format. Please note that since the Committee E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 84, Number 24 (Tuesday, February 5, 2019)]
[Notices]
[Page 1713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01055]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License for U.S. Government-Owned 
Invention

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with applicable laws and regulations, 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
Attn: Office of Research and Technology Applications, 1520 Freedman 
Drive, Suite 227, Fort Detrick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: Dr. Paul Michaels, Office of Research 
& Technology Applications, (301) 619-4145. For patent issues, Ms. 
Elizabeth Arwine, Patent Attorney, (301) 619-7808, both at telefax 
(301) 619-5034.

SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209 (e) and 37 
CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an 
exclusive, royalty-bearing, revocable license to United States Patent 
7,867,983, filed March 25, 2008, entitled ``Methods to Protect Skeletal 
Muscle Against Injury,'' to the University of Connecticut, having its 
principal place of business at 400 Farmington Avenue, Farmington, CT 
06032.
    Anyone wishing to object to grant of this license can file written 
objections along with supporting evidence, if any, within 15 days from 
the date of this publication. Written objections are to be filed with 
the Command Judge Advocate (see ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2019-01055 Filed 2-4-19; 8:45 am]
 BILLING CODE 5001-03-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.